Trupanion, Inc. (NASDAQ:TRUP – Get Rating) Director Howard E. Rubin sold 3,500 shares of the firm’s stock in a transaction on Tuesday, February 28th. The shares were sold at an average price of $58.85, for a total value of $205,975.00. Following the completion of the sale, the director now directly owns 227,855 shares in the company, valued at approximately $13,409,266.75. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Trupanion Price Performance
Shares of NASDAQ TRUP opened at $57.91 on Thursday. Trupanion, Inc. has a 52 week low of $40.77 and a 52 week high of $99.01. The firm has a 50-day simple moving average of $54.71 and a 200-day simple moving average of $57.00. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.22.
Trupanion (NASDAQ:TRUP – Get Rating) last issued its quarterly earnings results on Wednesday, February 15th. The financial services provider reported ($0.23) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.30) by $0.07. Trupanion had a negative net margin of 4.94% and a negative return on equity of 14.25%. The company had revenue of $246.01 million during the quarter, compared to the consensus estimate of $242.28 million. During the same quarter in the previous year, the firm earned ($0.16) earnings per share. The firm’s quarterly revenue was up 26.6% on a year-over-year basis. Equities research analysts predict that Trupanion, Inc. will post -0.98 EPS for the current year.
Institutional Investors Weigh In On Trupanion
Analyst Ratings Changes
A number of equities analysts have recently weighed in on the company. UBS Group cut their target price on Trupanion from $80.00 to $66.00 and set a “buy” rating on the stock in a research note on Friday, November 4th. Canaccord Genuity Group upped their target price on shares of Trupanion from $66.00 to $72.00 and gave the stock a “buy” rating in a research report on Thursday, February 16th. Piper Sandler upped their price target on shares of Trupanion from $53.00 to $63.00 and gave the company a “neutral” rating in a research report on Thursday, February 16th. Finally, Lake Street Capital increased their price target on shares of Trupanion from $67.00 to $75.00 and gave the stock a “buy” rating in a research note on Thursday, February 16th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Trupanion currently has an average rating of “Moderate Buy” and a consensus target price of $78.67.
About Trupanion
Trupanion, Inc engages in the provision of medical insurance for cats and dogs. It operates through the following segments: Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members.
Featured Articles
- Get a free copy of the StockNews.com research report on Trupanion (TRUP)
- Jack in the Box Pops On Tasty Results, Robust Outlook
- How Low Can Lowe’s Companies Go?
- Ambarella: An AI Play In The Making
- Terran Orbital’s New $2.4 Billion Contract is a Game Changer
- Wendy’s Price Firms After Sizzling Quarter And Juicy Outlook
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
